{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T13:49:52Z","timestamp":1773409792680,"version":"3.50.1"},"reference-count":25,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acta Obstet Gynecol Scand"],"published-print":{"date-parts":[[2013,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>A study was undertaken to assess the distribution of high\u2010risk <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content>\u2010genotypes in high\u2010grade cervical intraepithelial neoplastic lesions in Danish women.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>Observational, cross\u2010sectional.<\/jats:p><\/jats:sec><jats:sec><jats:title>Setting<\/jats:title><jats:p>Danish data from a multi\u2010centre study undertaken in 13 European countries.<\/jats:p><\/jats:sec><jats:sec><jats:title>Population<\/jats:title><jats:p>290 archived fixed biopsies with high\u2010grade cervical lesions from the Departments of Pathology at the University Hospitals in Hvidovre and Odense, Denmark.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Relevant histological samples were anonymized and shipped to a central laboratory for histopathology review and <jats:styled-content style=\"fixed-case\">PCR<\/jats:styled-content>\u2010testing for <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">DNA<\/jats:styled-content>. A standardised <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content>\u2010test methodology was utilised to enable comparison of <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content>\u2010genotype distribution.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of 290 Danish cervical samples, 276 were evaluated as histologically adequate and all of these were <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content>\u2010positive (<jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content><jats:sup>+<\/jats:sup>). Of the <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content><jats:sup>+<\/jats:sup> samples 77.9% were diagnosed with a single <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content>\u2010type, with cervical intraepithelial neoplasia (<jats:styled-content style=\"fixed-case\">CIN<\/jats:styled-content>)3 diagnosed in 82.3% and <jats:styled-content style=\"fixed-case\">CIN<\/jats:styled-content>2, <jats:styled-content style=\"fixed-case\">CIN<\/jats:styled-content>2\/3, adenocarcinoma in situ (<jats:styled-content style=\"fixed-case\">AIS<\/jats:styled-content>) and <jats:styled-content style=\"fixed-case\">AIS<\/jats:styled-content><jats:sup>+<\/jats:sup> other high\u2010grade lesion diagnosed in the remaining 17.7%. The most prevalent <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content>\u2010types were: <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content>16 (54.0%), <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content>33 (13.5%), <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content>31 (10.7%), <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content>18 (7.9%) and <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content>52 (4.7%). Of the <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content><jats:sup>+<\/jats:sup> samples, 21.4% were diagnosed with multiple <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content>\u2010types, with <jats:styled-content style=\"fixed-case\">CIN<\/jats:styled-content>3 diagnosed in 79.6% and <jats:styled-content style=\"fixed-case\">CIN<\/jats:styled-content>2, <jats:styled-content style=\"fixed-case\">CIN<\/jats:styled-content>2\/3, <jats:styled-content style=\"fixed-case\">AIS<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">AIS<\/jats:styled-content><jats:sup>+<\/jats:sup> other high\u2010grade lesion diagnosed in the remaining 20.4%. The most prevalent <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content>\u2010types were: <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content>16 (49.2%), <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content>31 (30.5%), <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content>52 (27.1%), <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content>51 (20.3%), <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content>18 (16.9%), <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content>33 (13.6%), <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content>45 (11.9%), with 0.7% unknown types.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p><jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content>16 and <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content>18 were detected in approximately 75% of high\u2010grade intraepithelial cervical lesions in a Danish population (single or multiple infections); these two genotypes are considered causative in at least 61.9% of the high\u2010grade intraepithelial lesions (single infection).<\/jats:p><\/jats:sec>","DOI":"10.1111\/aogs.12162","type":"journal-article","created":{"date-parts":[[2013,5,6]],"date-time":"2013-05-06T11:20:41Z","timestamp":1367839241000},"page":"1032-1040","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["<scp>HPV<\/scp>\u2010genotypes in high\u2010grade intraepithelial cervical lesions in Danish women"],"prefix":"10.1111","volume":"92","author":[{"given":"Benny","family":"Kirschner","sequence":"first","affiliation":[{"name":"Department of Gynecology &amp; Obstetrics Hvidovre University Hospital Copenhagen Denmark"},{"name":"Department of Pathology Hvidovre University Hospital Copenhagen Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doris","family":"Schledermann","sequence":"additional","affiliation":[{"name":"Department of Pathology Odense University Hospital Odense Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsiaryna","family":"Holl","sequence":"additional","affiliation":[{"name":"GlaxoSmithKline Biologicals Rixensart Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mats","family":"Rosenlund","sequence":"additional","affiliation":[{"name":"GlaxoSmithKline Biologicals Rixensart Belgium"},{"name":"Center for Pharmacoepidemiology Unit of Clinical Epidemiology Department of Medicine Karolinska Institutet Stockholm Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Raillard","sequence":"additional","affiliation":[{"name":"4Clinics Paris France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wim","family":"Quint","sequence":"additional","affiliation":[{"name":"DDL Diagnostic Laboratory Rijswijk the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anco","family":"Molijn","sequence":"additional","affiliation":[{"name":"DDL Diagnostic Laboratory Rijswijk the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Jenkins","sequence":"additional","affiliation":[{"name":"DDL Diagnostic Laboratory Rijswijk the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jette","family":"Junge","sequence":"additional","affiliation":[{"name":"Department of Pathology Hvidovre University Hospital Copenhagen Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,6]]},"reference":[{"key":"e_1_2_9_2_1","unstructured":"The Danish National Board of Health 2012 The Danish National Board of Health Copenhagen Denmark"},{"key":"e_1_2_9_3_1","unstructured":"F Engholm J Ferlay N Christensen TB Johannesen \u00c5 Klint JE K\u00f8tlum Association of the Nordic Cancer Registries Danish Cancer Society"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.a1284"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.22527"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/87.11.796"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.27713"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.23712"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65688-X"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.37.8.2508-2517.1999"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.855"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2008.03.022"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601024"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2011.10.020"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-2754"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.21282"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0463.2008.00019.x"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70286-8"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.3970"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61248-4"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)17398-4"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68439-0"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.3.979-983.2002"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(05)70101-7"},{"issue":"46","key":"e_1_2_9_26_1","first-page":"3971","article-title":"Quadrivalent HPV 6\/11\/16\/18 vaccine","volume":"169","author":"Kjaer SK","year":"2007","journal-title":"Ugeskr Laeger"}],"container-title":["Acta Obstetricia et Gynecologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Faogs.12162","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/aogs.12162","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T03:33:02Z","timestamp":1696476782000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/aogs.12162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["10.1111\/aogs.12162"],"URL":"https:\/\/doi.org\/10.1111\/aogs.12162","archive":["Portico"],"relation":{},"ISSN":["0001-6349","1600-0412"],"issn-type":[{"value":"0001-6349","type":"print"},{"value":"1600-0412","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"2012-07-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-04-29","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-06-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}